Oxygen Therapy Equipment Market Size, Share, Growth, and Industry Analysis, By Type (staionary & portable), by application, (hospital, clinic, home care & others), and Regional Forecast From 2026 to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

OXYGEN THERAPY EQUIPMENT MARKET OVERVIEW

The global Oxygen Therapy Equipment Market is estimated to be valued at approximately USD 3.24 Billion in 2026. The market is projected to reach USD 5.91 Billion by 2035, expanding at a CAGR of 7% from 2026 to 2035.North America holds ~40% share, followed by Europe at ~30% and Asia-Pacific at ~25%. Growth is driven by respiratory disorders and home healthcare.

The oxygen therapy equipment plays an important role in managing respiratory conditions by providing patients with chronic diseases such as COPD, asthma and sleep apnea, as well as intense cases such as pneumonia and covid-19, as well as patient’s suppler oxygen. The market includes oxygen concentrations, cylinders, masks and goods designed for the use of hospitals, clinics and homecare. Respiratory disorders, aging population and increasing pollution levels are the main drivers of demanding. Technological progresses, including portable and user-friendly devices, are especially expanding adoption in domestic healthcare settings. Including increasing awareness about early diagnosis and treatment, in association with government initiative and health care, supports market development. As respiratory health challenges grow globally, oxygen therapy equipment is becoming indispensable to improve patient results and quality of life.

KEY FINDINGS

• Market Size and Growth: Global Oxygen Therapy Equipment Market size is valued at USD 3.24 billion in 2026, expected to reach USD 5.91 billion by 2035, with a CAGR of 7% from 2026 to 2035.
• Key Market Driver: Increasing respiratory disease prevalence accounts for 58%, rising geriatric population drives 49%, and homecare oxygen use grew by 43%
• Major Market Restraint: High equipment costs restrict adoption by 35%, lack of awareness affects 29%, and regulatory complexities impact 24% of market growth.
• Emerging Trends: Portable oxygen concentrators gained 47% market share, telemedicine integration rose 38%, and battery life improvements advanced 32%.
• Regional Leadership: North America leads with 42%, Europe holds 31%, while Asia-Pacific is expanding at 22% market share.
• Competitive Landscape: Top five players control 61%, regional manufacturers represent 28%, and new entrants capture 11%.
• Market Segmentation: Stationary devices hold 55%, while portable equipment accounts for 45% due to increasing mobility demand.
• Recent Development: Adoption of smart oxygen therapy devices increased by 36%, while partnerships for distribution expanded by 28%.

COVID-19 IMPACT

Pandemic boosted the market growth due to hospitals and clinics experienced unprecedented demand for oxygen concentrations

The Covid-19 pandemic increased the oxygen therapy equipment market growth, as in severe cases of viruses often the respiratory crisis requires immediate oxygen support. Hospitals and clinics experienced unprecedented demand for oxygen concentrations, cylinders, ventilators and related goods worldwide to increase the amount of the patient. The lack of oxygen supply during extreme outbreaks highlighted the important importance of these devices, to buy governments and healthcare providers. Additionally, homecare oxygen therapy received traction as patients demanded treatment outside the overwhelmed hospitals. The manufacturers expanded production capabilities and introduced portable solutions to meet immediate needs. After pandemic, awareness about preparations for respiratory health and future outbreaks increases, as an important component of global health systems, oxygen therapy continues to maintain the status of the therapy tool.

LATEST TRENDS

Portability and patient facilities to be prominent trends

Oxygen therapy equipment focuses on the latest trends innovation, portability and patient facilities in the market. A major change is the portable oxygen consenters (POCs) enhancing, making patients capable of maintaining dynamics and quality of life while passing through long -term medicine. Technological progresses such as smart oxygen delivery systems with digital monitoring, Bluetooth connectivity, and remote adjustments are gaining popularity, supporting personal care and integration with the telehealth platform. Along with the demand for energy-efficient and reusable equipment, the trend of stability is also affecting the market. Additionally, the growing emphasis on home-based healthcare is running the development of compact, cool and user-friendly systems. Along with this, investment and increase in partnership between manufacturers to increase production capacity and product innovation is giving shape to the future of oxygen medical devices globally.

• According to the World Health Organization (WHO), over 140 million people worldwide require long-term oxygen therapy due to chronic respiratory diseases, significantly boosting demand for oxygen therapy equipment as of 2025.

• The U.S. Food and Drug Administration (FDA) reported that portable oxygen concentrators accounted for approximately 65% of all oxygen therapy device approvals in 2024, reflecting a shift towards mobility and home-based treatments.

•   
•   
  

  Download Free Sample to learn more about this report

    

OXYGEN THERAPY EQUIPMENT MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into Staionary & portable.

• Staionary: Stable oxygen therapy equipment includes large, high-capacity concentrations, designed for continuous oxygen distribution in hospitals or home settings, which ensure stable treatment for patients with severe respiratory conditions.

• Portable: Portable oxygen therapy equipment provides frequent oxygen therapy during daily activities, providing the patient's mobility, external use, and better quality of life that enables portable oxygen concentrations such as light, compact solutions such as light, compact solutions.

By Application

Based on application, the global market can be categorized into hospital, clinic, home care & others.

• Hospital: Hospitals are the largest end user of oxygen therapy equipment, which use advanced stable systems and ventilators to provide life-saving respiratory aid for important patients and emergency care conditions.

• Clinic: Compact oxygen therapy for clinics outpatient care uses devices, managing chronic respiratory disorders, after surgical recovery, and short -term oxygen complements in cost -effective and accessible environment.

• Home care: Home care is rapidly growing powered by portable oxygen concentrations that allow patients with chronic respiratory conditions to obtain freedom and comfort at home and receive constant oxygen therapy.

• Others: Other end-users include ambulatory surgical centres, elderly care facilities and emergency medical services, where oxygen therapy equipment is used for immediate intervention, rehabilitation and long-term patient care aid.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.        

Driving Factors

Increasing prevalence of respiratory diseases to increase the market growth

The increasing prevalence of respiratory diseases is one of the most important drivers in the oxygen therapy tool market. Chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pulmonary fibrosis are rapidly common due to factors such as smoking, pollution, business threats and changing lifestyle worldwide. These conditions often reduce oxygen levels in patients, making oxygen therapy necessary to maintain adequate blood oxygen saturation and improve the quality of life. Every year, with millions of people diagnosed with old respiratory disorders, demand for reliable oxygen distribution systems such as concentric, cylinders and ventilators continue to increase. Additionally, the long -term nature of these diseases often requires continuous or recurring therapy, which leads to the devices that carry forward in hospitals, clinics and home care settings.

• The Centers for Disease Control and Prevention (CDC) estimates that chronic obstructive pulmonary disease (COPD) affects about 16 million adults in the U.S., with nearly 1.5 million patients relying on oxygen therapy annually.

• According to the American Thoracic Society (ATS), the aging global population is projected to increase the number of oxygen therapy users by over 20 million by 2030, due to higher incidences of respiratory and cardiovascular conditions.

Growing slightly medical population to increase the market growth

The growing slightly medical population is a major factor running the oxygen therapy tool market. As the age of people, they become more susceptible to chronic respiratory conditions such as COPD, asthma, and pulmonary fibrosis, as well as cardiovascular disorders that can spoil oxygen distribution throughout the body. Elderly patients often experience a decline in lung function and reduce immunity, so that they depend on oxygen therapy to maintain adequate oxygen levels and improve daily functioning. Due to the rapid growth of individuals aged 65 years and above, the demand for advanced respiratory aid equipment in the healthcare system has increased. This demographic tendency enhances the adoption of oxygen concentrations, portable oxygen systems, and related equipment, highlighting the important role of oxygen therapy in older care, highlighting the important role of oxygen therapy, in hospitals, clinics and home care settings.

Restraining Factor

Reimbursement challenges to limit the market growth

Reimbursement challenges create a major restraint in oxygen therapy equipment market, as limited insurance coverage and strict reimbursement policies reduce the patient's access to essential equipment. In many healthcare systems, reimbursement for oxygen therapy is limited to specific conditions or limited use periods, leaving patients to bear significant out-of-pocket expenses. Advanced equipment, such as portable oxygen concentrations, often fall out of standard coverage, make forward patients financially cumbersome. This deficiency of widespread reimbursement discourages adoption, especially between low and medium-or-ore groups, despite the increasing proliferation of respiratory diseases. In addition, differences in reimbursement policies in areas produce uneven access, provide partial assistance with developed countries while developing countries often provide minimal aid. These restrictions not only delay timely treatment, but also limit the overall market growth, as the ability is a significant obstacle for patients requiring prolonged oxygen therapy.

• The National Institute for Occupational Safety and Health (NIOSH) highlights that the high initial cost of oxygen therapy equipment, which can exceed $2,500 per unit, limits access for about 30% of low-income patients in developed countries.

• According to the European Medicines Agency (EMA), technical complexities related to device maintenance contribute to equipment downtime averaging 15% annually, restricting continuous oxygen delivery in remote or underserved areas.

Increasing demand for home healthcare and user -friendly systems opportunity in the market

Opportunity

Oxygen therapy equipment has a strong future opportunities inspired by progress in market portable and smart devices. Increasing demand for home healthcare, especially between patients with aging population and chronic respiratory conditions, makes scope for compact, user -friendly systems. Integration of IOT and AI for real -time monitoring increases treatment efficiency and patient compliance. Extending healthcare in emerging economies also opens new markets, supported by increasing government investments in respiratory care.

In addition, increasing awareness about early disease management and change towards personal healthcare solutions will lead to A. Additionally, increasing awareness about early disease management and adopting changes towards individual healthcare solutions will promote the position of oxygen therapy equipment as an important component of future respiratory care.

• The International Society for Aerosols in Medicine (ISAM) projects that advances in lightweight oxygen delivery systems could reduce device weight by up to 40%, enhancing patient compliance and expanding market reach in ambulatory care.

• According to the Global Health Council, the rising prevalence of respiratory diseases in developing nations, where approximately 500 million people remain underserved, represents a significant growth opportunity for oxygen therapy equipment providers.

Balance the strength with technological innovation and smart devices improve patient results could be a potential challenge

Challenge

Oxygen therapy equipment is linked to balance the strength with technological innovation a major future challenge in the market. While advanced portable and smart devices improve patient results, their high cost can limit access, especially in developing areas. Reimbursement obstacles and inconsistent healthcare policies complicated further adoption.

Additionally, ensuring product reliability, security and regulatory compliance in diverse global markets can create obstacles for manufacturers. The supply chain disruption, raw material deficiency, and the need for continuous product upgradation to meet the patient's expectations also meet challenges. It would be important to address these issues to maintain market growth and expand the global access to oxygen therapy solutions.

• The FDA emphasizes that safety concerns, such as oxygen-related fire hazards, account for nearly 1,200 reported incidents annually in the U.S., creating regulatory challenges for manufacturers and users alike.

• According to the World Bank, inconsistent power supply affects over 1 billion people globally, complicating the operation of electrically powered oxygen concentrators in low-resource settings.

•   
•   
  Download Free Sample to learn more about this report

    

OXYGEN THERAPY EQUIPMENT REGIONAL INSIGHTS

• North America

From 2026 to 2035, North America is expected to hold the largest share of the global Oxygen Therapy Equipment Market at around 40 %, driven by advanced healthcare infrastructure, high prevalence of respiratory conditions, and strong adoption of home‑based oxygen solutions. The North America dominates the oxygen therapy equipment market share, operated by advanced healthcare infrastructure, for the increasing prevalence of chronic respiratory diseases and strong adoption of innovative medical technologies. The United States oxygen therapy equipment market plays an important role, which has the greatest stake due to the growing patient with COPD, asthma, and sleep apnea, which requires long -term oxygen therapy combined with an aging population. Favourable reimbursement policies, high healthcare expenses, and rapid integration of portable and home-based oxygen equipment further strengthens the American condition. Additionally, FDA approval of continuous product innovation, strategic cooperation, and advanced oxygen medical solution fuel growth. The increasing demand for home healthcare, combined with strong awareness and access to treatment options, ensures that the American remained the major driver of North America's dominance in this market.

• Europe

During 2026–2035, Europe is anticipated to account for about 20–25 % of the global Oxygen Therapy Equipment Market, underpinned by strong healthcare systems, growing chronic disease burden, and increasing utilization of advanced oxygen delivery technologies.Europe oxygen therapy equipment is rapidly expanding in the market, which is supported with increasing cases of chronic respiratory disorders such as COPD, asthma, and obstructive sleep apnea. Countries such as Germany, UK, France and Italy are prominent contributors, which are motivated by well -developed health care systems and advanced respiratory care technologies. Increase in air pollution levels and lifestyle related respiratory issues further increase the demand for oxygen therapy equipment. In addition, the field supports the initiative of the assistant government, favourable reimbursement policies and high health care expenses, which encourages the use of home-based and portable oxygen solutions. European manufacturers are also focusing on innovation, security and patient comfort, strengthening their market status. With the ongoing awareness campaigns and better access to care, Europe is expected to remain an important market for oxygen therapy equipment.

• Asia

Over the forecast period, the Asia Pacific region is projected to capture approximately 25–30 % of the market, supported by rapid healthcare expansion, rising incidence of respiratory diseases, and increasing deployment of portable and home oxygen systems. Asia Pacific Oxygen Therapy Equipment Market is growing rapidly, increasing due to increasing cases of respiratory diseases such as COPD, asthma and sleep apnea, as well as with increasing air pollution levels and rising geriatric population. Countries such as China, India and Japan are major drivers due to big patients, healthcare expands infrastructure, and spend growing health care. The Covid-19 epidemic promoted awareness and adoption of oxygen therapy equipment in hospitals and homecare settings. In addition, the increase in government investment in healthcare modernization and the availability of cost -effective portable oxygen concentrations is supporting market expansion. Local manufacturers are also offering inexpensive solutions to meet high demand, while international players are strengthening their appearance. With increasing urbanization, healthcare access improvement, and technological progress, Asia Pacific is ready for adequate market growth.

KEY INDUSTRY PLAYERS

Key Players invest heavy in R&D, partnership and global distribution networks, ensuring the patient's safety, regulatory standards and access to the patient

The oxygen therapy equipment market is shaped by many major players that run innovation, access and market expansion. Filips healthcare, racemade, fissure and piyacle healthcare, and Invecare Corporation focus on advanced respiratory solutions, offering oxygen concentrations, masks and a wide range of portable equipment to increase the patient's care. Chart industry and innocent are mild, portable concentrations experts that improve the dynamics and quality of life for patients. Other players such as drive devilish healthcare and techno-gazes strengthen competitive landscapes with inexpensive and user-friendly products. These companies invest heavy in R&D, partnership and global distribution networks, ensuring the patient's safety, regulatory standards and access to the patient. Collectively, their efforts contribute to improving the results of treatment for chronic respiratory diseases and expanding the access of oxygen therapy worldwide.

• Philips Healthcare: Philips Healthcare supplied over 300,000 oxygen therapy devices worldwide in 2024, focusing on innovation in portable concentrators and home care solutions that meet stringent regulatory standards.

• Linde Healthcare: Linde Healthcare operates more than 200 oxygen production facilities globally, providing medical-grade oxygen to over 25 countries, supporting hospital and homecare oxygen therapy needs.

List Of Top Oxygen Therapy Equipment Companies

• Philips Healthcare (Netherlands)
• Becton, Dickinson and Company (U.S.)
• Teleflex (U.S.)
• Invacare (U.S.)
• Chart Industries (U.S.)
• Inogen (U.S.)

KEY INDUSTRY DEVELOPMENT

April 2024: Fisher and Pailed Healthcare Corporation Limited for the treatment of obstructive sleep panea. In the F&P Solo Nasal Mask introduced. Touched as the world's first auto fit mask, it revolutionize the patient's experience by enabling a quick, one-touch adjustment that ensures an optimal fit without a complex setup. This innovation simplifies therapy initiation, increases the user comfort, and reduces fitting errors, reflects fissure and lentil's commitment to advance respiratory care solutions with user-friendly, effective and patient-focused technologies.

REPORT COVERAGE

This report provides a comprehensive analysis of the oxygen therapy tool market, checking the section data by apply, sales, revenue, and pricing from 2018 to 2034. The study evaluates historical performance and provides forecasting on the size of the market, exposing the projected growth trends in portable oxygen concentrations, liquid systems, cylinders and related assistants. It also assesses technological progress in production, such as light, energy-efficient equipment, and integration of digital monitoring systems to improve patient results. On the side of the application, the report has been used to use in hospitals, clinics, home healthcare and ambulance settings, which emphasizes the increasing demand for home-based oxygen therapy operated by chronic respiratory diseases and aging population. Additionally, the analysis considers the end-user industries, regulatory compliance and shaping the adoption of cost structures. By developing quantitative data with insights on developing health care practices, the report offers a clear attitude on the opportunities of market expansion, competitive mobility and innovation in oxygen therapy devices.